Novel ORC4L gene mutation in B-cell lymphoproliferative disorders

American Journal of the Medical Sciences

Volumn 338, Issue 6, 2009, Pages 527-529

  Radojkovic, Milica ^a   Ristic, Slobodan ^a   Divac, Aleksandra ^b   Tomic, Branko ^b   Nestorovic, Aleksandra ^b   Radojkovic, Dragica ^b  

^a Clinical Center Dr Dragisa Misovic   (Serbia)

^b Institute of Molecular Genetics and Genetic Engineering   (Serbia)

Author keywords

B cell lymphoproliferative disorders; ORC4L gene mutation; Prognosis

Indexed keywords

ALPHA INTERFERON; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ORIGIN RECOGNITION COMPLEX; ORIGIN RECOGNITION COMPLEX SUBUNIT 4 LIKE; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE; CELL CYCLE PROTEIN; ORC4L PROTEIN, HUMAN; PRIMER DNA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; DNA REPLICATION; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; TREATMENT RESPONSE; AMINO ACID SUBSTITUTION; GENETICS; HETEROZYGOTE; LYMPHOPROLIFERATIVE DISEASE; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; AGED; AMINO ACID SUBSTITUTION; B-LYMPHOCYTES; BASE SEQUENCE; CELL CYCLE PROTEINS; DNA PRIMERS; FEMALE; HETEROZYGOTE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MUTATION, MISSENSE; ORIGIN RECOGNITION COMPLEX;

EID: 73949125253     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181b7f17c     Document Type: Article

References (13)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-3918
2. Tanaka S, Diffley JF. Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. Genes Dev 2002;16:2639-2649
3. Dhar SK, Delmolino L, Dutta A. Architecture of the human origin recognition complex. J Biol Chem 2001;276:29067-29671
4. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002;71:333-374
5. Sasaki T, Gilbert DM. The many faces of the origin recognition complex. Curr Opin Cell Biol 2007;19:337-343
6. Quintana DG, Hou Zh, Thome KC, et al. Identification of ORC4L, a member of the human origin of replication recognition complex. J Biol Chem 1997;272:28247-28251
7. Available at: www.genecards.com. Accessed January 30, 2009.
8. Fröhling S, Nakabayashi K, Scherer SW, et al. Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22. Hum Genet 2001;108:304-309 (Pubitemid 32421742)
9. McNairn AJ, Gilbert DM. Overexpression of ORC subunits and increased ORC-chromatin association in transformed mammalian cells. J Cell Biochem 2005;96:879-887
10. Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 1994;83:1460-1466
11. Holte H, Suo Z, Smeland EB, et al. Prognostic value of lymphomaspecific S-phase fraction compared with that of other cell proliferation markers. Acta Oncol 1999;38:495-503.
12. Semple JW, Duncker BP. ORC-associated replication factors as biomarkers for cancer. Biotechnol Adv 2004;22:621-631
13. Obermann EC, Went P, Zimpfer A, et al. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis. BMC Cancer 2005;5:162.